Carisma Therapeutics Inc (CARM)

Jul 03, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE - The Malaysian Reserve

Jul 03, 2025

Jun 30, 2025

Carisma Therapeutics Inc. (NASDAQ:CARM) Given Average Recommendation of “Hold” by Brokerages - Defense World

Jun 30, 2025

Jun 27, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jun 27, 2025

Jun 25, 2025

After laying off most of its staff, struggling Carisma Therapeutics finds a merger partner - The Business Journals

Jun 25, 2025

Jun 24, 2025

Carisma Therapeutics, OrthoCellix enter definitive merger agreement - Yahoo Finance

Jun 24, 2025

Jun 23, 2025

Carisma Therapeutics stock soars after proposed merger with OrthoCellix By Investing.com - Investing.com India

Jun 23, 2025

Jun 22, 2025

Why CARISMA Therapeutics Plunged 12%: A Dive into the Unseen Drivers - AInvest

Jun 22, 2025

Jun 21, 2025

Carisma Therapeutics' 12% Drop: A Mystery Unveiled Through Order Flow and Peer Dynamics - AInvest

Jun 21, 2025

Jun 15, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Sold by Millennium Management LLC - Defense World

Jun 15, 2025

Jun 15, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Stock Position Decreased by Millennium Management LLC - Defense World

Jun 15, 2025

Jun 15, 2025

Millennium Management LLC Takes Position in Marker Therapeutics, Inc. (NASDAQ:MRKR) - Defense World

Jun 15, 2025

Jun 12, 2025

Carisma Therapeutics Secures Nasdaq Listing Approval - TipRanks

Jun 12, 2025

Jun 11, 2025

Is the 250% Carisma Therapeutics Stock (CARM) Surge a Sucker’s Rally? - The Globe and Mail

Jun 11, 2025

Jun 11, 2025

Dow Rises Over 50 Points; US Inflation Rate Increases In May - Benzinga

Jun 11, 2025

Jun 11, 2025

Carisma Therapeutics Stock (CARM) Retreats 35% After a Massive Rally - TipRanks

Jun 11, 2025

Jun 10, 2025

US Stocks Mixed; JM Smucker Shares Plunge After Q4 Results - Benzinga

Jun 10, 2025

Jun 10, 2025

Pre-market Movers: EVGN, WINT, CARM, UNCY... - RTTNews

Jun 10, 2025

Jun 10, 2025

Why Casey's General Stores Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 10, 2025

Jun 05, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Given Average Recommendation of “Hold” by Brokerages - Defense World

Jun 05, 2025

Jun 02, 2025

Carisma Therapeutics Reports Q1 2025 Financial Results - TipRanks

Jun 02, 2025

May 24, 2025

Carisma Therapeutics Inc (CARM): An Important Analyst Insights - Stocksregister

May 24, 2025

May 22, 2025

Layoff Tracker: Eikon Cuts Workforce by 15%, Citing ‘External Forces’ - BioSpace

May 22, 2025

May 20, 2025

Carisma Therapeutics Inc (NASDAQ: CARM) Stock Sentiment: What’s Wall Street Saying? - Stocksregister

May 20, 2025

May 14, 2025

Carisma Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025

May 14, 2025

CARISMA Therapeutics 2025 Q1 Earnings Improved Net Income by 51.2% - AInvest

May 14, 2025

May 08, 2025

Financial Metrics Unveiled: Carisma Therapeutics Inc (CARM)’s Key Ratios in the Spotlight - DWinneX

May 08, 2025

May 05, 2025

Carisma Therapeutics Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView

May 05, 2025

Apr 24, 2025

Caribou cuts 32% of staff, further purges pipeline to focus on 2 oncology CAR-T prospects - Fierce Biotech

Apr 24, 2025

Apr 23, 2025

Carisma Therapeutics to Present at Upcoming Conferences - Seeking Alpha

Apr 23, 2025

Apr 22, 2025

Biopharma restructurings reflect strategy of short-term pain for long-term gains - BioWorld MedTech

Apr 22, 2025

Apr 16, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Given Average Rating of “Hold” by Analysts - Defense World

Apr 16, 2025

Apr 15, 2025

Sagimet Biosciences (NASDAQ:SGMT) and Carisma Therapeutics (NASDAQ:CARM) Head-To-Head Review - Defense World

Apr 15, 2025

Apr 08, 2025

Philly weekly roundup: Carisma Therapeutics layoffs; PPA's AI ticketing; HiveBio's first cohort - Technical.ly

Apr 08, 2025

Apr 07, 2025

Carisma Therapeutics Inc’s Market Journey: Closing Weak at 0.19, Down -0.26 - DWinneX

Apr 07, 2025

Apr 06, 2025

CARISMA THERAPEUTICS Earnings Preview: Recent $CARM Insider Trading, Hedge Fund Activity, and More - Nasdaq

Apr 06, 2025

Apr 03, 2025

Carisma Therapeutics Focuses on Strategic Alternatives Amid Revised Operating Plan - MSN

Apr 03, 2025

Apr 02, 2025

Philly’s Carisma Therapeutics slashed its workforce to 6 from 46 for sale or wind down - MSN

Apr 02, 2025

Apr 02, 2025

Carisma Therapeutics Full Year 2024 Earnings: Misses Expectations - Yahoo Finance

Apr 02, 2025

Apr 02, 2025

Carisma Therapeutics (NASDAQ:CARM) Price Target Lowered to $1.00 at D. Boral Capital - Defense World

Apr 02, 2025

Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Apr 01, 2025

Apr 01, 2025

Carisma Therapeutics to Present at AASLD 2024 on Liver Fibrosis Treatment - MSN

Apr 01, 2025

Apr 01, 2025

Carisma winds down operations, lays off 95% of remaining staff - Fierce Biotech

Apr 01, 2025

Mar 31, 2025

Penn spinout Carisma Therapeutics lays off 84% of its staff, explores possible sale - The Business Journals

Mar 31, 2025